glp 1 pregnancy risk GLP-1 exposure in does not clearly raise major birth defect GLP-1 Receptor Agonist Exposure During

Cost and access: Branded semaglutide remains expensive and subject to supply shortages, pushing patients to explore semaglutide alternatives

14.4 million children in India are already battling obesity, it brings a host of challenges, from increased health risks like diabetes and heart disease to social stigma, mobility issues, and rising healthcare costs, making it a complex global concern This sharp surge in obesity isnt just a public health concernits reshaping how we approach wellness, nutrition, and chronic disease management

The safety profile of concomitant GLP-1 receptor agonist and metformin therapy remains controversial in current literature

doi:10.1016/j.bbi.2021.01.034

Yes, there are skin-prick tests, oral challenge tests, and other forms of testing available